I. Stappaerts et al., LONG-TERM FOLLOW-UP OF PULMONARY-DISEASE CAUSED BY MYCOBACTERIUM-AVIUM IN A PREVIOUSLY HEALTHY PATIENT, Acta Clinica Belgica, 48(3), 1993, pp. 202-208
A 64-year-old white male with cavitary lung disease is presented. Myco
bacterium avium was isolated from sputa and gastric lavage and the Ame
rican Thoracic Society criteria for nontuberculous mycobacterial disea
se were met. Seven years follow-up and treatment regimens are discusse
d. This case illustrates that medical treatment of M. avium pulmonary
disease can be disappointing and requires regular clinical, radiologic
al, microbiological and haematological reassessment to evaluate effica
cy and toxicity of therapy.Despite in vitro resistance to the standard
antimycobacterial agents, prolonged treatment regimens can be success
ful and are the therapy of choice. Another drug combination, based on
in vitro susceptibility patterns, has to be started for patients who f
ail to respond or who relapse. Lifelong treatment may be necessary to
keep the patient stable and to prevent further destruction of lung par
enchyma.